The Underwriting Challenge: When the EBITDA Number Lies
A sponsor brings you a manufacturing platform generating a reported $10 million in EBITDA. The debt package, priced at 5.5× leverage, implies a $55 million senior facility. Before a single covenant is drafted or a term sheet circulated, the first and most consequential underwriting question must be answered: Is that $10 million real?
In leveraged credit, the gap between reported and underwritable EBITDA is not a footnote; it is a structural risk. Every dollar of unjustified add-back is multiplied by the deal’s leverage multiple, directly inflating the debt load relative to true cash flow capacity. At a 5.5× multiple, a $1 million EBITDA overstatement means the borrower carries $5.5 million more in debt than the business can actually support.
This dynamic has sharpened scrutiny considerably in the current environment. The bridge between reported and adjusted EBITDA has become, in the words of practitioners, a primary red flag for diligence teams that must be proactively addressed rather than explained away after commitment. Sophisticated lenders no longer treat the seller’s adjusted EBITDA schedule as a conclusion; they treat it as a starting point for independent verification.
This article walks through the complete normalization methodology: the three-tier adjustment taxonomy, key coverage metrics, illustrative calculations, critical red flags, and the underwriting checklist that separates defensible credit decisions from structurally compromised ones.
The Framework: A Three-Tier Adjustment Taxonomy
Experienced credit teams structure EBITDA normalization across three distinct layers. Each tier has a different burden of proof and a different risk profile if improperly claimed.
Tier 1: Definitional Adjustments (Low Dispute, High Acceptance)
These are mechanical: adding back interest expense, income taxes, depreciation, and amortization to arrive at a reported EBITDA baseline. These are universally accepted but must be tied directly to audited financial statements. Any divergence between the EBITDA bridge and the audited income statement must be reconciled and explained before proceeding.
Tier 2: Quality-of-Earnings Adjustments (Evidence Required)
These remove items that are genuinely non-recurring: a settled litigation cost, a one-time severance tranche from a completed restructuring, a non-recurring consulting engagement, or transaction advisory fees specific to the sale process itself. The critical test is whether each item is real, evidenced, and will stay out of the run-rate after closing. If an “exceptional” cost appears in three consecutive periods of historical financials, it is no longer exceptional by any defensible standard.
Tier 3: Normalization Adjustments (Highest Scrutiny)
These fix recurring items that are priced economically incorrectly: typically owner compensation above the market replacement cost of the role, related-party lease payments at below-market rates, family-member payroll without a substantive operational function, or personal discretionary expenses run through the business. Normalization adjustments are structurally different from QoE adjustments: the underlying cost is real and will continue post-closing, but at a different market-rate level.
“Normalized EBITDA goes further [than Adjusted EBITDA] to reflect the earnings a buyer can sustainably underwrite after considering steady-state staffing, market compensation, and necessary reinvestment.”, Windsor Drake, Adjusted EBITDA: The Complete Guide (2026)
Normalized EBITDA can actually be lower than adjusted EBITDA when the business requires incremental overhead under new ownership, a reality that sell-side presentations routinely obscure and that buy-side lenders must independently model.
The Analysis: Walking the Bridge on a $10M EBITDA Manufacturing Company
Consider a middle-market manufacturer presenting the following EBITDA bridge to prospective lenders:
| Line Item | Seller Claim | Lender Underwritten | Variance |
|---|---|---|---|
| Reported Net Income | $4,200,000 | $4,200,000 | – |
| + Interest, Taxes, D&A (Tier 1) | $3,800,000 | $3,800,000 | – |
| = Reported EBITDA | $8,000,000 | $8,000,000 | – |
| + One-time legal settlement (Tier 2) | $600,000 | $400,000 | $200,000 rejected, recurring exposure not resolved |
| + Excess owner compensation (Tier 3) | $900,000 | $500,000 | $400,000 reduced, market replacement cost applied |
| + Non-recurring ERP implementation (Tier 2) | $500,000 | $500,000 | Accepted, invoices and one-time vendor contract confirmed |
| = Adjusted / Normalized EBITDA | $10,000,000 | $9,400,000 | ($600,000) |
At a 5.5× leverage multiple, that $600,000 EBITDA haircut reduces supportable debt capacity by $3.3 million, a structurally material difference that changes both the pricing and the risk profile of the facility.
Coverage Metrics: Building on the Normalized Base
With a lender-underwritten EBITDA of $9.4 million, the underwriter must model two core coverage ratios using the actual debt structure:
- Total Leverage Ratio: Total Funded Debt ÷ Normalized EBITDA = $51.7M ÷ $9.4M = 5.5×
- Fixed Charge Coverage Ratio (FCCR): (EBITDA − CapEx − Cash Taxes − Distributions) ÷ (Interest + Required Principal) = ($9.4M − $0.8M − $0.6M − $0.5M) ÷ ($3.1M + $1.5M) = 1.63×
A well-structured middle-market deal should demonstrate FCCR coverage no lower than 1.20× under base-case projections, with sufficient headroom to absorb a 15–20% EBITDA compression scenario without covenant breach. The Fixed Charge Coverage Ratio is especially critical for asset-light businesses with significant operating lease obligations; these companies can show healthy debt service coverage while struggling to meet total fixed commitments.
Industry Standards: What Institutional Lenders Actually Require
Credit Performance Context
Normalization discipline matters most under stress, and the credit cycle has provided a pointed reminder of what happens when EBITDA is underwritten aggressively at peak leverage. Key data points from institutional sources:
📊 Credit Performance Data Box
- Moody’s Leveraged Loan Default Rate (H1 2025): The leveraged loan default rate was projected at approximately 7.5% for year-end 2025, with the historical long-term average standing at 3.4%, meaning the market has been running at roughly double its historical norm. Distressed exchanges accounted for approximately 64% of all defaults in the first half of 2025. (Source: Moody’s Ratings, U.S. Credit Review & Outlook, July 2025)
- S&P Global Leveraged Loan Default Forecast: S&P Global Ratings expected the U.S. leveraged loan default rate to fall to approximately 1% by September 2025 under conventional payment-default definitions, from 1.26% in September 2024. In a pessimistic scenario incorporating tariff and macroeconomic shocks, S&P projected the default rate could nearly double to 2.5%. (Source: S&P Global Ratings, Default, Transition, and Recovery, November 2024)
- Pitchbook LCD Trailing 12-Month Default Rate (August 2025): Using a conventional definition (bankruptcies and missed payments only), the trailing 12-month default rate for U.S. leveraged loans stood at approximately 1.36%. Including distressed liability management exercises, the combined rate rose to 4.37%. (Source: Pitchbook LCD Distressed Weekly, as cited by Valuation Research Corporation, February 2026)
- Cliffwater Direct Lending Index (CDLI), Senior Credit Losses: The broader CDLI, representing both senior and non-senior middle market loans, produced an estimated annualized credit loss of approximately 1.47%, underscoring the structural importance of first-lien position and tight covenant packages in direct lending portfolios. (Source: Morgan Stanley / Cliffwater, Evolution of Direct Lending, 2025)
- Senior Secured Loan Recovery Rates: Senior broadly syndicated loan recovery rates have historically averaged close to 70%, though Moody’s analysis of more recent vintage leveraged loans projects first-lien senior secured recovery in the 61% range, reflecting increased leverage and thinner junior capital cushions in modern capital structures. (Source: BancAlliance, Analysis of Moody’s Study on Leveraged Lending Recovery Rates)
Common Red Flags in EBITDA Presentations
Experienced credit teams flag the following patterns as high-risk signals requiring deeper diligence or adjustment rejection:
- The Reported-to-Adjusted Gap Exceeds 25–30% of EBITDA: The typical reported-to-adjusted EBITDA gap in the lower middle market runs 20–30%. Wider spreads signal aggressive add-backs that will face systematic challenge during lender QoE review and that may not survive institutional credit committee scrutiny.
- Revenue Pulled Forward Near Period-End: Strong quarter-end revenue that is driven by early invoicing, aggressive recognition, or end-of-period deal acceleration is GAAP-compliant and still a significant warning sign for cash flow repeatability.
- Margin Expansion Driven by Deferred Investment: EBITDA margins that have spiked due to paused hiring, deferred maintenance, or reduced marketing spend will not be sustainable. The business cannot continue operating at that run-rate without paying the deferred bill post-closing.
- Customer Concentration Hidden by Structure: Revenue that appears diversified across multiple customer entities may, on closer examination, represent a single end-client operating behind multiple legal entities or channel partners. The underlying credit risk remains concentrated.
- Anticipated Cost Savings Not Yet in the Run-Rate: Projected synergies or cost savings that depend on post-closing management actions should be excluded from normalized EBITDA at underwriting. Lenders should not extend credit against earnings that have not yet been demonstrated.
- Stock-Based Compensation Add-Backs in Leverage Ratio Calculation: Adding back SBC when calculating Debt/EBITDA for the purpose of determining debt capacity inflates available leverage against genuine compensation costs that must be replaced under new ownership.
Underwriting Checklist: EBITDA Normalization Due Diligence
The following step-by-step framework reflects institutional lender best practices for independently verifying and stress-testing a borrower’s EBITDA bridge prior to credit approval.
Step 1: Obtain Source Documentation
- ☐ Request 3 years of CPA-reviewed or audited financial statements (minimum LTM if audits unavailable)
- ☐ Obtain monthly management accounts for the trailing 12 months
- ☐ Collect the seller’s adjusted EBITDA schedule and QoE report (if available)
- ☐ Request general ledger trial balance for the LTM period
Step 2: Construct an Independent EBITDA Bridge
- ☐ Reconcile from GAAP net income to reported EBITDA, tie to audited statements
- ☐ Categorize every claimed add-back by tier (Definitional / QoE / Normalization)
- ☐ Apply the “three-year recurrence test”: if a cost appeared in three of the past four years, it is recurring
- ☐ Apply market-rate replacement analysis to all owner compensation and related-party transactions
- ☐ Independently verify that any implemented run-rate cost savings are evidenced in actual expense data, not projected
Step 3: Revenue Quality Analysis
- ☐ Disaggregate revenue by customer, product line, and geography for the trailing three years
- ☐ Identify any customer representing >10% of revenue and assess contract duration and renewal risk
- ☐ Analyze month-by-month revenue pattern for period-end concentration or pull-forward signals
- ☐ Confirm revenue recognition policy aligns with economic delivery of goods or services
Step 4: Build the Coverage Model
- ☐ Calculate Total Leverage Ratio on lender-underwritten EBITDA (target: ≤5.5× for senior secured)
- ☐ Calculate FCCR including all lease obligations and required principal amortization (minimum: 1.20×)
- ☐ Model a base case, a downside case (−15% EBITDA), and a stress case (−25% EBITDA)
- ☐ Identify the EBITDA level at which first covenant breach occurs; this is your structural floor
Step 5: Assess Ongoing Capital Requirements
- ☐ Obtain 3 years of capital expenditure history, disaggregated between maintenance and growth CapEx
- ☐ Confirm maintenance CapEx has not been systematically deferred to inflate near-term cash flow
- ☐ Calculate normalized Free Cash Flow to Debt Service after maintenance CapEx and cash taxes
Step 6: Final Documentation Requirements
- ☐ Independent third-party Quality of Earnings report from a recognized accounting firm (required for transactions above $10M EBITDA)
- ☐ Audited financial statements or, at minimum, reviewed statements for the most recent two fiscal years
- ☐ Signed management representation letter confirming completeness of add-back disclosures
- ☐ Customer contract copies for any customer representing >15% of revenue
Key Takeaways: Five Risk Management Principles for EBITDA Underwriting
- The lender’s normalized EBITDA is never the seller’s adjusted EBITDA. Seller-provided schedules are a starting point for independent verification, not a conclusion. Every material add-back must be independently documented, tiered, and stress-tested against the recurrence test before being credited in the leverage calculation.
- Adjustment quality matters as much as the headline multiple. At a common middle-market multiple of 6×–8×, a $320,000 reduction in accepted EBITDA represents $1.9M–$2.6M of enterprise value and a corresponding reduction in supportable debt capacity. Small differences in normalized EBITDA have large structural consequences.
- Coverage ratio discipline is non-negotiable in a higher-rate environment. With the leveraged loan default rate running at historically elevated levels through 2024–2025, lenders who underwrote to thin FCCR cushions on aggressively normalized EBITDA are experiencing the consequences. An FCCR of 1.20× on base-case is a floor, not a target.
- Distressed exchanges have permanently complicated the default rate signal. With distressed exchanges comprising approximately 64% of all “default” events in H1 2025 per Moody’s data, traditional trailing 12-month default rates no longer capture true credit stress. Underwriters must supplement default rate analysis with real-time monitoring of distress ratios, PIK toggle activity, and covenant amendment frequency within their portfolio.
- The three-year recurrence test is the most practical single safeguard in the lender’s toolkit. Any cost that has appeared in three of the past four fiscal years is, by definition, a recurring operating cost of the business. Accepting it as a one-time add-back inflates normalized EBITDA, overstates debt capacity, and shifts credit risk from the borrower to the lender, precisely where disciplined underwriting must draw the line.
